128 related articles for article (PubMed ID: 11043574)
1. Identification and characterization of constitutively active Smad2 mutants: evaluation of formation of Smad complex and subcellular distribution.
Funaba M; Mathews LS
Mol Endocrinol; 2000 Oct; 14(10):1583-91. PubMed ID: 11043574
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling.
Souchelnytskyi S; Tamaki K; Engström U; Wernstedt C; ten Dijke P; Heldin CH
J Biol Chem; 1997 Oct; 272(44):28107-15. PubMed ID: 9346966
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
4. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
5. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Liu F; Pouponnot C; Massagué J
Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative Smad2 mutants inhibit activin/Vg1 signaling and disrupt axis formation in Xenopus.
Hoodless PA; Tsukazaki T; Nishimatsu S; Attisano L; Wrana JL; Thomsen GH
Dev Biol; 1999 Mar; 207(2):364-79. PubMed ID: 10068469
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta-independent shuttling of Smad4 between the cytoplasm and nucleus.
Pierreux CE; Nicolás FJ; Hill CS
Mol Cell Biol; 2000 Dec; 20(23):9041-54. PubMed ID: 11074002
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
11. TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling.
Abdollah S; Macías-Silva M; Tsukazaki T; Hayashi H; Attisano L; Wrana JL
J Biol Chem; 1997 Oct; 272(44):27678-85. PubMed ID: 9346908
[TBL] [Abstract][Full Text] [Related]
12. Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
De Bosscher K; Hill CS; Nicolás FJ
Biochem J; 2004 Apr; 379(Pt 1):209-16. PubMed ID: 14715079
[TBL] [Abstract][Full Text] [Related]
13. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
Tsukazaki T; Chiang TA; Davison AF; Attisano L; Wrana JL
Cell; 1998 Dec; 95(6):779-91. PubMed ID: 9865696
[TBL] [Abstract][Full Text] [Related]
14. Endogenous patterns of TGFbeta superfamily signaling during early Xenopus development.
Faure S; Lee MA; Keller T; ten Dijke P; Whitman M
Development; 2000 Jul; 127(13):2917-31. PubMed ID: 10851136
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a Smad2 homologue from Schistosoma mansoni, a transforming growth factor-beta signal transducer.
Osman A; Niles EG; LoVerde PT
J Biol Chem; 2001 Mar; 276(13):10072-82. PubMed ID: 11152451
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers.
Yanagisawa K; Uchida K; Nagatake M; Masuda A; Sugiyama M; Saito T; Yamaki K; Takahashi T; Osada H
Oncogene; 2000 May; 19(19):2305-11. PubMed ID: 10822381
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of zebrafish smad2, smad3 and smad4.
Dick A; Mayr T; Bauer H; Meier A; Hammerschmidt M
Gene; 2000 Apr; 246(1-2):69-80. PubMed ID: 10767528
[TBL] [Abstract][Full Text] [Related]
18. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.
Kawabata M; Inoue H; Hanyu A; Imamura T; Miyazono K
EMBO J; 1998 Jul; 17(14):4056-65. PubMed ID: 9670020
[TBL] [Abstract][Full Text] [Related]
19. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
20. Notch signaling modulates the nuclear localization of carboxy-terminal-phosphorylated smad2 and controls the competence of ectodermal cells for activin A.
Abe T; Furue M; Kondow A; Matsuzaki K; Asashima M
Mech Dev; 2005 May; 122(5):671-80. PubMed ID: 15817224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
